CIM
ALXO icon

CIM Investment Management’s ALX Oncology ALXO Stock Holding History

CIM Investment Management’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-10,706
Closed -$87K – 225
2022
Q2 		$87K Hold
10,706
– – 0.04% 222
2022
Q1 		$181K Buy
+10,706
New +$183K 0.06% 237
2021
Q4 		– Sell
-3,155
Closed -$233K – 300
2021
Q3 		$233K Buy
+3,155
New +$210K 0.07% 251
2021
Q2 		– Sell
-3,155
Closed -$233K – 301
2021
Q1 		$233K Buy
+3,155
New +$248K 0.07% 261

Other funds holding ALXO

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

CIM Investment Management's ALXO Position: Q3 2022 in Review

CIM Investment Management sold out of ALX Oncology (ALXO) in Q3 2022, closing a stake of 10,706 shares — an estimated $87K sold.

CIM Investment Management first reported a position in ALXO in Q1 2021 and held it in 4 quarters. The position peaked at $233K in Q3 2021. 99 funds tracked by Wall St. Rank hold ALXO as of Q3 2022.

  • CIM Investment Management reported no remaining ALX Oncology position as of Q3 2022 after selling out during the quarter.
  • CIM Investment Management sold 10,706 ALX Oncology shares in Q3 2022, an estimated $87K.
  • CIM Investment Management first reported a position in ALX Oncology in Q1 2021 and held it in 4 quarters.
  • CIM Investment Management's ALX Oncology position peaked at $233K in Q3 2021.
  • 99 funds tracked by Wall St. Rank held ALX Oncology as of Q3 2022.

Based on CIM Investment Management's 13F filing for Q3 2022, filed 14 Nov 2022.